SCHEMBL13247985

SCHEMBL13247985

C=C1N(CC=O)c2ccccc2C1(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.43
▸ HTT P42858 4/20 0.43
▸ KMT2A Q03164 8/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ TP53 P04637 2/20 0.36
▸ MAPT P10636 8/20 0.36
▸ MEN1 O00255 7/20 0.36
▸ THRB P10828 3/20 0.36
▸ RECQL P46063 3/20 0.36
▸ POLB P06746 2/20 0.36
▸ ALPG P10696 2/20 0.36
▸ BLM P54132 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ USP2 O75604 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ S1PR2 O95136 1/20 0.36
▸ PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8480751 0.85 L3MBTL1 (0.46) LMNAHTTKMT2ACYP1A2CYP2D6
SCHEMBL6091601 0.80 KMT2A (0.46) LMNAHTTKMT2ACYP1A2CYP2D6
Hydrochloric Acid SCHEMBL10583826 0.79 LMNA (0.39) LMNAHTTKMT2ACYP1A2CYP2D6
SCHEMBL9736556 0.78 HTT (0.41) LMNAHTTKMT2ACYP1A2CYP2D6
SCHEMBL30996203 0.77 CYP1A2 (0.55) LMNAHTTKMT2ACYP1A2CYP2D6
SCHEMBL8629800 0.77 KMT2A (0.44) LMNAHTTKMT2ACYP1A2CYP2D6
SCHEMBL1372846 0.77 P2RX1 (0.49) KMT2ACYP1A2CYP2D6TP53MAPT
SCHEMBL5573253 0.77 KMT2A (0.47) LMNAHTTKMT2ACYP1A2CYP2D6
SCHEMBL7478345 0.77 KMT2A (0.44) LMNAHTTKMT2ACYP1A2CYP2D6
SCHEMBL9738900 0.75 KMT2A (0.46) LMNAHTTKMT2ACYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100212737-A1 DYE INCLUDING AN ANCHORING GROUP IN ITS MOLECULAR STRUCTURE SONY CORPORATION (JP) 2010-08-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100212737-A1 DYE INCLUDING AN ANCHORING GROUP IN ITS MOLECULAR STRUCTURE CBR3, CYB5R3, CBR1 LMNA 3097/4885HTT 4042/4885KMT2A 2301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback